查詢結果分析
來源資料
頁籤選單縮合
題名 | Comparison of Fluorine-18-Fluorodeoxyglucose PET with Technetium-99m-MDP Whole Body Scan in a Patient with Bone Metastases from Unknown Primary Cancer=氟-18-去氧葡萄糖正子造影和鎝-99-m-MDP骨閃爍造影在轉移性骨癌的應用比較:一病例報告 |
---|---|
作者 | 孫盛生; 蔡世傳; 譚台笙; 高嘉鴻; | 書刊名 | 核子醫學雜誌 |
卷期 | 13:3 2000.09[民89.09] |
頁次 | 頁185-188 |
分類號 | 414.93 |
關鍵詞 | 氟-18-去氧葡萄糖全身正子造影; 鎝-99-m-MDP骨閃爍全身造影; 轉移性骨癌; 洤F-FDG PET; [fee6]Tc-MDP whole body scan; Bone metastases; |
語文 | 英文(English) |
中文摘要 | 本文主要報告一位有鎖骨病理性骨折的46歲男性病人,被安排一系列之檢查,包括電腦斷層掃描、腹部超音波等等,但臨床上卻找不到確定的原發性腫瘤,故進一步安排氟-18-去氧葡萄糖(FDG)的全身正子造影(PET)檢查來尋找原發性腫瘤以及評估全身轉移的情形。此病例再一次印證了PET在尋找原發性腫瘤及評估全身轉移上的高度價值。 |
英文摘要 | At present, metastatic bone disease is usually assessedusing technetium-99m-methylene diphosphonate (99mTc-MDP) whole body scan, which is a sensitive but nonspecific method for evaluation of osseous metabolism. Several studies have shown that fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDG PET) is a useful imaging tool for detection of bone metastases and differentiation of benign and malignant lesions. Another advantage of 18F-FDG PET is that all organ systems can be visualized and evaluated in a single whole-body imaging session. We present a case of a 46-year-old male patient with suspected bone metastases from unknown primary cancer who was placed in an oncology screening program that included 18F-FDG PET whole-body scan for primary tumor detection and staging. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。